Girindus makes your API come true We label your innovative Active Pharmaceutical Ingredient and metabolites with stable- (13C) or radio- (14C, 3H) isotopes using our extensive chemical and radiolabeling expertise. Girindus AG Buchenallee 20 P.O. Box 100 259 D-51402Bensberg Germany
Tel +49 2204 926 900 Fax + 4 9 2204 926 990
[email protected] Girindus America, Inc. 8560 Reading Road Cincinnati, Ohio 45215-0027 USA
Tel +1 513 679 3002
Custom Synthesis of Active Pharmaceutical Ingredients and Key Intermediates PROCESS
R&D
SCALE-UP
&
PRODUCTION
CUSTOMER
SERVICE
• Pre-Clinical through Early Clinical Trials
• Phase I, II, III and Launch
• Regular constructive dialogue
• Process Optimization
• Prompt and flexible response
• Grams to Kilograms
• Process Validation
• Process Research and Development
•
• Open communication on project progression
Documentation
• Small Scale Synthesis
• Commercial Quantities up to Multi-Tons
• Proven reliability for delivery time and quality
• Pilot Plant
• Over 5 0 Reaction Vessels
• Versatile production streams
• 40 to 120 L Reactors
• 100 L to 5000 L
• Regulatory affairs
• -80*Cto150°C
• -80°Cto280#C
• High Pressure Reaction Capabilities up to 150 bar
•
• Strategic orientation for a unique market
• Radiosynthesis Capabilities • Oligonucleotide Production
Biotransformations
• Lab Scale to 10,000 LFermerrtors • Yeast, Bacterial and Isolated Enzymes
F a x + 1 5 1 3 679 3053
[email protected] • Proven cGMP capability
www.girindus.com
i
Girindus Antutnse HVIUS savt
• at G i r i n d u s .
Visit us during CPHI 2002, Booth S 60